The National Eye Institute is seeking research co-development partners and licensees for an AAV2-based delivery system or eyedrop formulation to deliver Pigment Epithelium-Derived Factor peptides. This initiative aims to address inherited retinal diseases through a gene-agnostic approach.
The National Eye Institute (NEI) seeks research co-development partners and/or licensees for the development of an AAV2-based delivery system or an eyedrop formulation to deliver a Pigment Epithelium- Derived Factor (PEDF) peptide as a gene-agnostic approach to treating inherited retinal diseases.
Original title: “Government Owned Invention Available for License: Pigment Epithelium-Derived Factor Peptides and Their Use for Treating Retinal Degeneration”